Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis

ObjectiveThis study aimed to evaluate mecapegfilgrastim utilization for the prophylaxis of chemotherapy-induced neutropenia in cancer patients and to assess changes caused by the National Health Insurance Coverage (NHIC) policy.MethodsIndividual patient data, including demographics, medical insuranc...

Cijeli opis

Bibliografski detalji

Glavni autori:	Wenqing Fang, Jizhong He, Ying Wang, Yulei Zhu, Xiaodan Qian, Dan Su, Jinhong Gong, Jingjing Shang, Yuan He, Hong Wu, Xin Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-02-01
Serija:	Frontiers in Pharmacology
Teme:	mecapegfilgrastim national health insurance coverage adjuvant chemoradiotherapy utilization binary logistic regression
Online pristup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1546261/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!